№ files_lp_4_process_3_110338
File format: docx
Character count: 44632
File size: 285 KB
Detailed clinical and pathological guidelines for documenting resected hepatoblastoma specimens, including synoptic reporting requirements, tumor classification, and specimen handling protocols for accreditation purposes.
Year:
2025
Region:
United States
Subject:
Hepatoblastoma pathology and resection reporting
Document type:
Clinical protocol
Organization:
College of American Pathologists (CAP)
Authors:
Jessica L. Davis, MD; Soo-Jin Cho, MD, PhD; Grace Kim, MD; Sarangarajan Ranganathan, MD; Delores Lopez-Terrada, MD, PhD; Allison O’Neal, MD; Arun Rangaswami, MD
Intended audience:
Pathologists, laboratory staff, oncology teams
Version:
5.0.0.1
Protocol posting date:
June 2025
Required use date:
June 2024
Procedures covered:
Resection (lobectomy, segmentectomy, explanted liver, other)
Excluded procedures:
Biopsy
Tumor types covered:
Pediatric hepatoblastoma
Accreditation requirement:
Synoptic reporting with core and conditional elements
Reporting format:
Synoptic, with data elements presented as outlined in case summary
Changes in version:
Accreditation statement update, eCP explanatory note electronic link updates
Contact:
[email protected]
Glossary included:
Yes
Ancillary studies:
Immunohistochemistry, molecular studies
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / City:
United States
Subject:
Pediatric Rhabdomyosarcoma Biopsy Procedures
Document Type:
Clinical Protocol
Organization:
College of American Pathologists (CAP)
Authors:
Jessica L. Davis, MD; Erin Rudzinski, MD; Michael Arnold, MD, PhD; Archana Shenoy, MD; Lea Surrey, MD; Aaron Weiss, DO
Target Audience:
Pathologists, Laboratory Staff
Effective Period:
June 2024 – present
Version:
5.0.0.1
Accreditation Requirements:
CAP Laboratory Accreditation Program
Procedures Covered:
Core biopsy, incisional biopsy, excisional biopsy
Tumor Types Covered:
Pediatric rhabdomyosarcoma and ectomesenchymoma variants
Excluded Procedures:
Adult rhabdomyosarcoma, tumor resections
Reporting Format:
Synoptic report with core and conditional data elements
Glossary:
Defines roles of authors and expert contributors
Contact:
[email protected]
Year:
2025
Region / City:
Navarre, Stark County, Ohio
Subject:
Sewer Service Charges
Document Type:
Ordinance
Issuing Body:
Village Council of Navarre
Author:
Village Council
Target Audience:
Residents, commercial, industrial, and institutional customers in Navarre
Period of Effect:
Starting April 1, 2026
Approval Date:
March 2, 2026
Amendment Date:
February 2, 2026 (First Reading), February 16, 2026 (Second Reading)
Modification:
Increased sewer service charges and expansion of wastewater treatment plant funding
Year:
2017
Region / City:
N/A
Topic:
Retinoblastoma, Germ Cell Tumors, Hepatoblastoma
Document Type:
Medical Case Study
Organization / Institution:
N/A
Author:
Carlos Rodriguez-Galindo, MDA
Target Audience:
Medical Professionals
Period of Action:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2019
Journal:
World Journal of Clinical Cases
Volume:
7
Issue:
7
Pages:
872–880
DOI:
10.12998/wjcc.v7.i7.872
Article type:
Case report
Field:
Pediatric surgery; Hepatobiliary surgery; Oncology
Medical condition:
Hepatoblastoma
Surgical technique:
Robot-assisted hepatectomy with gallbladder preservation
Patient age:
3 years
Institution:
PLA General Hospital
Country:
China
Authors:
Di-Xiang Chen; Shan-Jie Wang; Ya-Nan Jiang; Mu-Chuan Yu; Jun-Zhen Fan; Xian-Qiang Wang
Corresponding author:
Xian-Qiang Wang
Publisher:
Baishideng Publishing Group Inc.
License:
Creative Commons Attribution Non Commercial (CC BY-NC 4.0)
Received date:
December 11, 2018
Accepted date:
March 16, 2019
Online publication date:
April 6, 2019
Version:
4.1.0.0
Protocol Posting Date:
December 2022
Recommended Use:
Clinical care purposes
Not Required For Accreditation:
Yes
Procedures Covered:
Biopsy (core, incisional, other)
Tumor Types Covered:
Pediatric hepatoblastoma
Excluded Procedures:
Resection
Excluded Tumor Types:
Other primary malignant hepatic tumors
Authors:
Jessica L. Davis, MD; Soo-Jin Cho, MD, PhD; Grace Kim, MD; Sarangarajan Ranganathan, MD; Delores Lopez-Terrada, MD, PhD; Allison F. O’Neal, MD; Arun Rangaswami, MD
Guidance Committees:
CAP Cancer and CAP Pathology Electronic Reporting Committees
Core Data Elements:
Routinely reported
Non-Core Data Elements:
Indicated with +
Updates:
WHO 5th edition, Expert Consultation updated from Conditional to Optional
Target Audience:
Pathologists, oncologists, clinical researchers
Document Type:
Clinical protocol / case summary
Year:
2016
Region / City:
Not specified
Subject:
Pediatric hepatoblastoma pathology
Document Type:
Clinical protocol
Organization / Institution:
Children’s Oncology Group, CAP Cancer and Pathology Electronic Reporting Committees
Authors:
Erin Rudzinski, MD; Sarangarajan Ranganathan, MD; John Hicks, MD; Grace Kim, MD
Intended Audience:
Pathologists, clinical laboratory staff
Protocol Version:
3.2.0.2
Accreditation Requirement:
Recommended for clinical care, not required for accreditation
Sample Handling:
Formalin-fixed tissue for morphology, snap-frozen tumor for molecular studies, viable tumor for cytogenetics
Tumor Classification:
Epithelial and mesenchymal hepatoblastoma subtypes
Ancillary Studies:
Immunohistochemistry for INI1, Glypican 3, Beta-catenin
Staging System:
Children’s Oncology Group staging
Surgical Procedures:
Biopsy, lobectomy, segmentectomy, explanted liver
Data Collection:
Tumor site, size, focality, margins, lymphovascular invasion, lymph node status, distant metastases, serum AFP level
Version:
4.4.0.0
Protocol Posting Date:
June 2021
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2022
Authors:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Note:
Accreditation Requirements
Year:
2021
Region / City:
Global
Theme:
Oncology, Breast Cancer
Document Type:
Protocol
Organization / Institution:
CAP (College of American Pathologists)
Author:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Target Audience:
Medical professionals, pathologists
Period of Validity:
From March 2022
Date of Approval:
June 2021
Date of Changes:
June 2021
Year:
2024
Region / City:
Not specified
Subject:
Pathology, Oncology
Document Type:
Protocol
Organization / Institution:
CAP (College of American Pathologists)
Author:
Uma G. Krishnamurti, MD, PhD; Kimberly H. Allison, MD; Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Target Audience:
Pathologists, Medical Institutions
Period of Validity:
March 2025
Approval Date:
Not specified
Date of Last Change:
June 2024
Year:
2019
Region / city:
Not specified
Theme:
Oncology
Document type:
Clinical Protocol
Authors:
Erin Rudzinski, MD; Bruce Pawel, MD; Armita Bahrami, MD; M. John Hicks, MD
Target audience:
Healthcare professionals involved in pediatric oncology
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
February 2019
Version:
4.2.1.0
Protocol Posting Date:
June 2025
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2026
Year:
2025
Region / City:
Not specified
Subject:
Renal cell carcinoma, nephrectomy, tumor classification
Document Type:
Protocol
Institution:
CAP (College of American Pathologists)
Author:
Paari Murugan, MD, FCAP*, Robert W. Allan, MD, FCAP*, Lara R. Harik, MD, FCAP*
Target Audience:
Pathologists, medical professionals involved in cancer diagnostics
Effective Period:
March 2026 onward
Approval Date:
June 2025
Revision Date:
Not specified
Year:
2016
Region / City:
Orlando, FL
Theme:
Biomechanics, Orthopaedics
Document Type:
Conference Paper
Organization / Institution:
Orthopaedic Research Society
Authors:
Sueyoshi T, Small SR, Elliot JB, Gibbs GE, Seale RB, Berend ME, Ritter MA
Target Audience:
Medical professionals, researchers in orthopaedics
Period of Activity:
March 5-8, 2016
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Southampton, UK
Topic:
Oesophago-gastric cancer, neoadjuvant therapy, cardiopulmonary exercise testing
Document Type:
Research Article
Institution:
University of Southampton, Southampton NIHR Biomedical Research Centre
Author:
Malcolm A West, William CA Baker, Saqib Rahman, Alicia Munro, Sandy Jack, Michael PW Grocott, Timothy J Underwood, Denny ZH Levett
Target Audience:
Medical professionals, oncologists, researchers
Period of Effectiveness:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Version:
5.1.0.0
Protocol Posting Date:
September 2025
CAP Laboratory Accreditation Program Protocol Required Use Date:
June 2026
Note:
The changes included in this current protocol version affect accreditation requirements. The new deadline for implementing this protocol version is reflected in the above accreditation date.
Resection:
Includes pneumonectomy, lobectomy, segmentectomy, and wedge resection
Carcinoma:
Includes non-small cell carcinoma, small cell carcinoma, and carcinoid tumor of the lung
Year:
2025
Region / City:
Global
Theme:
Medical Protocol, Oncology
Document Type:
Protocol
Institution:
CAP (College of American Pathologists)
Author:
Frank Schneider, MD, Kirtee Raparia, MD, FCAP
Target Audience:
Medical professionals in pathology and oncology
Period of Validity:
2025-2026
Approval Date:
September 2025
Modification Date:
September 2025
Year:
2023
Region:
China
Subject:
Male rectal cancer, laparoscopic surgery, postoperative urogenital function
Document Type:
Clinical trial protocol
Organization:
Sun Yat-sen University, Multiple affiliated hospitals
Author:
Research Team
Target Audience:
Medical professionals, researchers, clinicians
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Singapore
Theme:
Hepatocellular carcinoma, Surgical resection
Document type:
Meta-analysis
Author:
Aaron JL Lee, Andrew GR Wu, Kuo Chao Yew, Vishal G Shelat
Target audience:
Medical professionals, Researchers
Period of validity:
Not specified
Approval date:
February 1, 2023
Date of changes:
Not specified
Year:
2024
Region / City:
N/A
Topic:
Medical protocol
Document Type:
Protocol
Organization / Institution:
CAP Laboratory Accreditation Program
Authors:
Julie C. Fanburg-Smith, MD, FCAP; Paari Murugan, MD, FCAP; Andrew Horvai, MD, PhD; Fernanda Amary, MD, PhD; Meera Hameed, MD, FCAP; Michael J. Klein, MD.
Target Audience:
Pathologists, medical professionals in oncology
Effective Period:
March 2025
Approval Date:
June 2024
Date of Changes:
June 2024
Year:
2020
Protocol Version:
4.2.0.1
Protocol Posting Date:
February 2020
Required Use Date:
February 2020
Subject:
Primary carcinoma of the vagina
Procedure:
Resection (includes vaginectomy)
Tumor Types Included:
Squamous cell carcinoma, adenocarcinoma and variants, carcinosarcoma, neuroendocrine carcinoma, mixed epithelial–neuroendocrine tumors
Staging System:
pTNM (8th Edition, AJCC Staging Manual), 2018 FIGO Cancer Report
Issuing Organization:
College of American Pathologists
Program:
CAP Laboratory Accreditation Program
Committees:
CAP Cancer Committee; CAP Pathology Electronic Reporting Committee
Authors:
Saeid Movahedi-Lankarani, MD; Uma Krishnamurti, MD, PhD; Debra A. Bell, MD; George G. Birdsong, MD; Charles V. Biscotti, MD; Christopher N. Chapman Jr, MD; Dina H. Kandil, MD; Veronica Klepeis, MD, PhD; Anthony G. Montag, MD; Christopher N. Otis, MD
Document Type:
Cancer protocol and surgical pathology reporting guideline
Applicable Specimens:
Definitive primary cancer resection specimens
Exclusions:
Biopsy specimens; cytologic specimens; lymphoma; sarcoma; recurrent or metastatic tumors resected separately
Year:
2010–2022
Region / City:
Hyogo, Japan
Subject:
Biliary Tract Cancer, Sarcopenia, Surgical Outcomes
Document Type:
Clinical Study
Institution:
Meiwa Hospital, Department of Surgery
Authors:
Shinichi Ikuta, Tsukasa Aihara, Takayoshi Nakajima, Meidai Kasai, Naoki Yamanaka
Target Audience:
Oncologists, Surgeons, Clinical Researchers
Patient Cohort:
211 patients undergoing BTC resection
Primary Tumor Sites:
Intrahepatic bile duct, Extrahepatic bile duct, Gallbladder, Ampulla of Vater
Follow-up Method:
Disease-specific survival (DSS), Relapse-free survival (RFS)
Ethics Approval:
Institutional Ethics Committee of Meiwa Hospital, approval No. 2022-36
Year:
2021
Region / City:
Australia
Topic:
Healthcare, Medicare
Document Type:
Legislative Amendment
Organization:
Australian Department of Health
Author:
Medical Services Advisory Committee (MSAC)
Target Audience:
Specialist gastroenterologists, surgical endoscopists
Effective Period:
From 1 January 2022
Approval Date:
25 November 2021
Amendment Date:
N/A
Changes Description:
Amendments to MBS item 32230 for endoscopic mucosal resection (EMR) for large colorectal polyps
Related Legislation:
Guaranteeing Medicare – changes to the Medicare Benefit Schedule
Description:
Legislative amendment to clarify time frame for EMR service following diagnostic colonoscopy for specified colorectal polyp treatments.
Year:
2021
Organisation:
International Collaboration on Cancer Reporting
Document type:
Histopathology reporting guide
Subject:
Gastrointestinal stromal tumour (GIST)
Scope:
Pathology reporting of resection specimens for GIST
Exclusions:
Metastatic GIST specimens
Edition:
1st edition
Applicable staging system:
Pathological TNM staging
Evidence framework:
NHMRC levels of evidence
Intended users:
Pathologists reporting GIST resection specimens
Related publications:
Gastrointestinal Stromal Tumour (GIST) Histopathology Reporting Guide – Biopsy Specimens; Soft Tissue Sarcoma Histopathology Reporting Guide – Resection Specimens